Moderna's Q3 Sales, 2021 Guidance Hit By Coronavirus Vaccine Supply Hiccups

Quarterly Sales Miss Expectations By $1bn

 
• By Alaric DeArment

The company sees better times ahead for mRNA-1273, with supply contracts raising guidance for 2022, not to mention progress in its non-COVID-19 pipeline.

Moderna vaccine
Moderna reported lower-than-expected revenues in 3Q • Source: Shutterstock

More from Earnings

More from Business